Genfit S.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,899.30
1,614.40
527.00
284.00
118.00
69
Cost of Goods Sold (COGS) incl. D&A
2,865.20
3,922.50
-
-
-
-
Gross Income
965.90
2,308.10
-
-
-
-
SG&A Expense
13,265.60
19,854.00
21,484.00
40,098.00
62,078.00
75,546
EBIT
14,494.90
22,439.20
21,510.00
40,078.00
63,491.00
76,912
Non Operating Income/Expense
573.20
231.80
282.00
289.00
252.00
530
Interest Expense
77.60
213.40
49.00
123.00
2,168.00
10,990
Pretax Income
13,830.10
21,998.30
20,840.00
39,596.00
64,765.00
87,170
Income Tax
1,178.00
4,972.80
3,705.00
5,929.00
6,161.00
7,649
Consolidated Net Income
12,652.10
17,025.50
17,135.00
33,667.00
58,604.00
79,521
Net Income
12,652.10
17,025.50
17,135.00
33,667.00
58,604.00
79,521
Net Income After Extraordinaries
12,652.10
17,025.50
17,135.00
33,667.00
58,604.00
79,521
Net Income Available to Common
12,652.10
17,025.50
17,135.00
33,667.00
58,604.00
79,521
EPS (Basic)
0.62
0.74
0.70
1.28
1.25
2.55
Basic Shares Outstanding
20,193.70
22,977.00
24,696.30
26,354.60
-
31,167.20
EPS (Diluted)
0.63
0.74
0.69
1.28
-
2.55
Diluted Shares Outstanding
20,193.70
22,977.00
24,841.90
26,354.60
-
31,167.20
EBITDA
14,020.40
22,138.30
21,002.00
39,279.00
61,959.00
75,477
Other Operating Expense
263.40
277.10
45.00
535.00
1.00
-
Non-Operating Interest Income
169.20
422.50
437.00
316.00
642.00
202

About Genfit

View Profile
Address
Parc Eurasante
Loos Nord-Pas-de-Calais 59120
France
Employees -
Website http://www.genfit.com
Updated 07/08/2019
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. Its research and development efforts are focused on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver.